Skip to main content
Eton Pharmaceuticals, Inc. logo

Eton Pharmaceuticals, Inc. — Investor Relations & Filings

Ticker · ETON ISIN · US29772L1089 US Manufacturing
Open in API
Filings indexed 358 across all filing types
Latest filing 2018-11-13 Regulatory Filings
Country US United States of America
Listing US ETON

About Eton Pharmaceuticals, Inc.

https://etonpharma.com/

Eton Pharmaceuticals, Inc. is a pharmaceutical company focused on developing and commercializing treatments for rare diseases. The company's strategy involves sourcing, acquiring, and developing therapies to serve small, underserved patient populations. Eton manages the complete drug development lifecycle, from navigating clinical trials and the regulatory approval process to bringing the final products to market. It actively seeks meaningful therapies from a global network of partners to build a diversified portfolio of treatments.

Recent filings

Filing Released Lang Actions
Regulatory Filings 2018
Regulatory Filings
2018-11-13 English
Regulatory Filings 2018
Regulatory Filings
2018-11-09 English
Regulatory Filings 2018
Regulatory Filings
2018-11-08 English
8-A12B
Regulatory Filings Classification · 95% confidence The document is a Form 8-A filed with the SEC, which is used for the registration of certain classes of securities pursuant to Section 12(b) or (g) of the Securities Exchange Act of 1934. It includes details about the registration of common stock on NASDAQ and references a prior S-1 registration statement. The document is a regulatory filing related to securities registration, not a financial report, earnings release, or other types of filings. It is not an announcement of a report but the actual registration statement form. Therefore, it fits best under Regulatory Filings (RNS). The document length is 3754 characters, which is relatively short but contains the full form text, not just an announcement.
2018-11-08 English
FORM S-1/A
Capital/Financing Update Classification · 100% confidence The document is a Form S-1/A, which is an amendment to a registration statement filed with the SEC under the Securities Act of 1933. It is used for registering securities for an initial public offering (IPO) or other public offerings. The text includes details about the offering, the company, risk factors, management discussion, and other typical sections of a registration statement prospectus. This is not an annual report, earnings release, or any other financial report type. It is a capital markets filing related to the company's financing and securities offering. Therefore, the appropriate classification is Capital/Financing Update (CAP). The document length is substantial and contains detailed offering information, consistent with a capital raising filing.
2018-11-05 English
S-1/A
Capital/Financing Update Classification · 100% confidence The document is a Form S-1/A Registration Statement filed with the SEC, specifically an amendment to the Form S-1 registration statement for Eton Pharmaceuticals, Inc. It is related to the initial public offering (IPO) of common stock. The text includes details about the offering, underwriting, company overview, risk factors, and product pipeline. This type of filing is a capital markets document used to register securities for sale to the public, not a financial report, earnings release, or management discussion. It is not an announcement of a report but the actual registration statement itself. Therefore, it fits the category of Capital/Financing Update (CAP), which covers updates on company fundraising and financing activities such as IPO registration statements.
2018-10-31 English

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.